Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Unc-5 homolog C-like protein (UNC5CL) is a human protein encoded by the UNC5CL gene on chromosome 6. It shows peptidase activity and is involved in the positive regulation of the JNK cascade and canonical NF-kappaB signaling, where it reportedly inhibits NF-kappaB-dependent transcription by preventing NF-kappaB from binding to DNA targets[1][9][4][8]. It is expressed in the cytosol, centrosome, and membrane, with tissue distribution notably in the gastrointestinal tract and kidney[1][7]. Disease relevance is suggested by an association with cardia cancer, though its characterization as a classical drug target (such as a receptor or enzyme with validated therapeutic ligands) is currently lacking[1][7][9]. The protein may also participate in the netrin signaling pathway and has been annotated with peptidase and potentially netrin receptor molecular activities but remains insufficiently characterized as a therapeutic target[1][4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Unc-5 homolog C-like protein (UNC5CL).